|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12Q 1/6883 | (2018.01) |
| C12Q2600/106 | (2013.01) | ||
| C12Q 1/6883 | (2013.01) | ||
| C12Q2600/158 | (2013.01) | ||
| C12Q2600/156 | (2013.01) |
| (11) | Patento numeris | 3695012 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18803806.1 |
| Europos patento paraiškos padavimo data | 2018-10-11 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-08-19 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-03-08 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/055377 |
| Data | 2018-10-11 |
| (87) | Numeris | WO 2019/075181 |
| Data | 2019-04-18 |
| (30) | Numeris | Data | Šalis |
| 201762570985 P | 2017-10-11 | US |
| (72) |
XIN, Yurong , US
GROMADA, Jesper , US
CHENG, Xiping , US
DEWEY, Frederick , US
TESLOVICH DOSTAL, Tanya , US
SCHURMANN, Claudia , US
BARAS, Aris , US
ABUL-HUSN, Noura , US
|
| (73) |
Regeneron Pharmaceuticals, Inc. ,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION |
| INHIBITION OF HSD17B13 IN THE TREATMENT OF LIVER DISEASE IN PATIENTS EXPRESSING THE PNPLA3 I148M VARIATION |